Stock Analiz

Solesence, Inc. SLSN

Package Goods/Cosmetics · data as of November 13, 2026

$1.52Market cap $107M
Open the interactive analysis →

Solesence, Inc. (SLSN) is a consumer discretionary company listed in the US with a market value of about $107M. In the twelve months to September 30, 2026 it had revenue of $61M and net income of $3M, a net margin of 4.5%.

Its overall Stock Analiz score is 2.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (1/5).

Key numbers: a P/E of 50.7, a price to free cash flow of 13.0, 5-year revenue growth of 29% a year, a 5-year average ROIC of -1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 59% below the current price.

About Solesence

Solesence is listed in the US and classified in package goods/cosmetics. Revenue went from $10M in 2014 to $62M in 2025, growth of about 18.1% a year. It was profitable in 4 of the last 10 years in our data. Its share count rose by 196% over three years (dilution for shareholders). It spends 7% of revenue on research and development.

Score: 2.2 / 5

Value1/5
Future growth4/5
Track record2/5
Financial health3/5
Shareholder returns1/5

Checks passed

  • P/FCF below 20
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • ROE above 15%
  • Positive free cash flow

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%
  • Profitable 5 years in a row

Valuation

P/E (TTM)50.7
Forward P/E—
P/FCF13.0
P/S1.8
P/B6.4
EV/EBITDA23.8
PEG—
Dividend yield0.00%
FCF yield7.7%
Shareholder yield0.0%
Intrinsic value vs. price−59%

Growth and quality

Revenue growth (1 yr)18.6%
Revenue growth (5 yrs, per year)29.4%
EPS growth (5 yrs, per year)-7.8%
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-1.1%
ROIC (5-yr avg.)-1.1%
Profitable years (of last 10)4
Years paying a dividend—

Financials, last 10 years

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$61M$62M$52M$37M$37M$29M$17M$13M$14M$12M$11M
Net income$3M$3M$1M-$5M-$3M$2M$989000-$3M-$2M-$789000-$1M
Free cash flow$8M-$11M-$3M-$3M-$4M$447000-$3M-$4M-$2M-$1M-$369000
EPS (diluted)$0.04$0.04$0.02$-0.10$-0.10$0.10$0.06$-0.16$-0.12$-0.06$-0.08
Net margin4.5%4.5%2.1%-13.2%-7.0%7.9%5.8%-24.0%-14.7%-6.3%-11.9%
ROIC—8.8%8.0%-22.1%-11.3%11.4%18.7%-50.2%-146.2%-21.9%-35.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Solesence’s P/E ratio?

About 50.7, based on the last twelve months of diluted earnings per share.

Is Solesence stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 59% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Solesence pay a dividend?

Not currently.

Is Solesence a good stock to buy?

We do not give buy or sell advice. Solesence scores 2.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.